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Abstract:  Marine algae produce a cocktail of halogenated metabolites with potential 
commercial value. Structures exhibited by these compounds go from acyclic entities with a 
linear chain to complex polycyclic molecules. Their medical and pharmaceutical 
application has been investigated for a few decades, however other properties, such as 
antifouling, are not to be discarded. Many compounds were discovered in the last years, 
although the need for new drugs keeps this field open as many algal species are poorly 
screened. The ecological role of marine algal halogenated metabolites has somehow been 
overlooked. This new research field will provide valuable and novel insight into the marine 
ecosystem dynamics as well as a new approach to comprehending biodiversity. 
Furthermore, understanding interactions between halogenated compound production by 
algae and the environment, including anthropogenic or global climate changes, is a 
challenging target for the coming years. Research of halogenated metabolites has been 
more focused on macroalgae than on phytoplankton. However, phytoplankton could be a 
very promising material since it is the base of the marine food chain with quick adaptation 
to environmental changes, which undoubtedly has consequences on secondary metabolism. 
This paper reviews recent progress on this field and presents trends on the role of marine 
algae as producers of halogenated compounds. 
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1. Introduction  
Marine algae produce a wide variety of remarkable natural compounds, usually referred to as 
secondary metabolites because they are not involved in the basic machinery of life [1]. Although these 
molecules often contribute to only a very small fraction of the organism total biomass [2], the 
contribution of these compounds to survival may sometimes be comparable to metabolites resulting 
from the primary metabolism [3]. In that sense, the use of the term “secondary metabolite” seems less 
appropriate since these compounds also contribute to growth, reproduction and defense and thus play a 
primary role for the organism integrity.  
Many of these secondary metabolites are halogenated, reflecting the availability of chloride and 
bromide ions in seawater. Interestingly, bromide is more frequently used by algae for organohalogen 
production, although chlorine occurs in higher concentrations than bromine in seawater. Marine 
halogenated compounds comprise a varied assembly of compounds, ranging from peptides, 
polyketides, indoles, terpenes, acetogenins and phenols to volatile halogenated hydrocarbons [4]. The 
prevalence of halogens is not similar in marine algae: chlorine and bromine appear to be the main 
halogens used to increase biological activity of secondary metabolites, whereas iodine and fluorine 
remain quite unusual within the chemical structures [5]. However, some orders of brown algae such as 
Laminariales accumulate and use iodine for halogenation processes. For example, the kelp Laminaria 
digitata accumulates iodine to more than 30,000-times the concentration found in seawater, 
representing an average content of 1% of dry weight [6]. In fact, iodination is more frequent in brown 
algae than in red and green algae metabolites [6]. As a result, only less than 1% of secondary 
metabolites from of brown algae contain bromine or chlorine in contrast with as much as 90 and 7% of 
red and green algal compounds, respectively [7].  
Halogenation often provides these compounds with interesting key features and marine algae hold 
diverse and unique biosynthetic pathways for the production of halogenated metabolites. The 
halogenated sesterterpenes, neomangicols A–C, isolated from the marine fungus Fusarium [8], offer a 
striking example of the halogenation effect. Neomangicol A and B display in vitro cytotoxic effect 
toward the HCT-116 human colon tumor cell line, while their nonhalogenated analog neomangicol C 
was shown to be inactive [8].  
Biological properties of halogenated compounds have been researched for the past decades, with 
results showing antibacterial, antifungal, antiviral, anti-inflammatory, antiproliferative, antifouling, 
antifeedant, cytotoxic, ichthyotoxic, and insecticidal activity [9]. Research major focal points 
indubitably have been the discovery and characterization of new halogenated compounds, along with a 
remarkable effort toward the evaluation of their possible biomedical and biotechnological applications. 
Also, chemical profiles have been used to differentiate cryptic species but the chemotaxonomic value 
of natural halogenated compounds has been questioned due to geographical and seasonal variations in 
the chemical composition of algal species [10]. The ecological role of marine halogenated metabolites, 
alongside with other natural compounds, has been disregarded, although a few halogenated metabolites 
have been shown to have important and critical roles on the community structure of marine ecosystems 
in previous years [11–17]. In fact, most of the publications on marine ecological issues rarely include a 
chemical approach of compounds responsible for the ecological interactions found. Excellent reviews 
on marine natural compounds have been recently published [9,18,19], with no particular emphasis on Mar. Drugs 2010, 8                          
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halogenated metabolites. These showed a variety of structure types that were isolated from a wide 
range of marine organisms, including microorganisms and phytoplankton, macroalgae, sponges, 
cnidarians, bryozoans, molluscs, tunicates, echinoderms and true mangrove plants. During 2009, new 
naturally occurring algal halogenated compounds were found, most of them with little or no reported 
biological activity. Reports on the ecological role of algal natural compounds, presenting both 
chemical and ecological approaches were still few. The present paper focuses on halogenated 
compounds only, and is restricted to micro and macroalgae as natural sources. It attempts to provide an 
overview of new marine halogenated compounds reported in 2009 and to examine progress and 
present trends on the role of marine algae as producers of halogenated compounds. 
2. Macroalgae  
Interest in the actual marine natural compounds responsible for such a wide range of properties is 
far more recent and new compounds are still being discovered and isolated, chemical structures 
elucidated and properties being sorted out, with the aim of finding new molecular entities with 
industrial application. From time to time, a new compound emerges as particularly promising in a 
specific area and additional testing starts to allow further pharmacological evaluation. 
Many compounds have been found in marine macroalgae in recent years, mainly in red and brown 
algae, and fewer in green algae [9]. Among all marine macroalgae, red algae are the main producers of 
halogenated compounds. Laurencia (family Rhodomalaceae, order Ceramiales, class Rhodophyceae, 
phylum Rhodophyta) is considered one of the most prolific genera [20,21], being mainly found in 
tropical, subtropical, and temperate coastal waters. It has been intensively screened over the last fifty 
years, although a variety of new halogenated molecules are still being reported. Characteristically, the 
halogenation degree found in compounds from Laurencia is relatively high [19]. Diterpenes 
sesquiterpenes, triterpenes, and C15-acetogenins are the main secondary compounds of this genus 
[22,23] with which antimicrobial [24], antifeedant [25], antihelmintic [26,27] and cytotoxic [28,29] 
properties are generally associated.  
Five new chlorinated compounds, C15 acetogenin en-ynes (1–5), were obtained from Laurencia 
glandulifera collected from the island of Crete (Figure  1). Four of them were evaluated for their 
cytotoxicity toward HT-29 (colorectal adenocarcinoma), MCF-7 (mammary adenocarcinoma), PC-3 
(prostate adenocarcinoma), HeLa (cervical adenocarcinoma), and A431 (epidermoid carcinoma) 
human tumor cell lines, but no significant activity was found [30]. The characteristic terminal cis  
ene-yne moiety is also present in C15 eight-membered cyclic ethers previously isolated from   
L. glandulifera collected on the Crete Island, which exhibited antistaphylococcal activity with 
minimum inhibitory concentrations (MICs) in the range of 8–256 mg/mL [31]. 
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Figure 1. Structures of compounds 1–5 isolated from Laurencia glandulifera. 
 
Elatol (6)(Figure  2), a halogenated sesquiterpene alcohol, commonly found in many species of 
Laurencia, and known for its potent antibacterial activity, was isolated for the first time in Laurencia 
microcladia, collected in the Southern Brazilian coast [32]. Previous analysis of anti-herbivory 
proprieties of metabolites from Laurencia species (including elatol) have been conducted but no 
investigation had been reported for Laurencia microcladia. Elatol anti-herbivory properties were 
investigated using the black sea urchin Echinometra lucunter, but it was found that this species can 
tolerate elatol, at least in the concentrations tested [32]. However, this compound was able to deter 
feeding of Thalassia by reef fishes with a reduced loss of Thalassia by 60% and was shown to be a 
very efficient deterrent against the sea urchin Diadema antillarum, reducing grazing by 86% [11]. 
However, anti-herbivory proprieties could not be detected by testing the compound on the black sea 
urchin Echinometra lucunter.  
Laurencia saitoi, with exceptionally few reported halogenated compounds [25] in the past, was 
found to produce four novel halogenated sesquiterpenes: 10-bromo-3-chloro-2,7-epoxychamigr-9-en-
8-ol (7), 2,10-dibromochamigra-2,7-dien-9-ol (8), (9S)-2-bromo-3-chloro-6,9-epoxybisabola-7(14),10-
diene (9), and (9R)-2-bromo-3-chloro-6,9-epoxybisabola-7(14),10-diene (10)[33](Figure 2).  In 
addition, other brominated compounds were already reported for different macroalgal species, namely 
aplysistatin, a well known antileukemic agent [34,35], 5-acetoxypalisadin B, palisadin A, palisadin B 
belonging to a series of antimicrobial compounds, and 2,3,5,6-tetrabromoindole [36]. Cytotoxicity of 
the isolated compounds was evaluated by the MTT method, all the tested compounds being found 
inactive [36]. New brominated sesquiterpenes and a norsesquiterpene were also reported from the 
same species [37], namely 2-hydroxyluzofuranone (11), 2-hydroxyluzofuranone B (12), 
4-hydroxypalisadin C (13), and 2-bromo--ionone (14)(Figure 2). 
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Figure 2. Structures of halogenated compounds 6–14 isolated from Laurencia saitoi. 
 
Other red algal genera have also been screened and interesting findings were recently reported. 
From the chemical-rich genus Plocamium, a South African red algae Plocamium cornutum yielded 
five halogenated monoterpenes (15–19) from which two are new (compounds 18–19)(Figure 3). The 
antiplasmodial activity against the chloroquine sensitive strain of the most frequent and deadly human 
malaria parasite Plasmodium falciparum was tested. Although the compounds were significantly less 
active than standard chloroquine, compounds 16 and 17 containing 7-dichloromethyl moiety were the 
most active ones (IC50 = 16 and 17 μM, respectively), followed by compound 15 (IC50 = 27 Μm), 
which contains an aldehyde functional group at this position, while the new compounds were 
essentially inactive [38].  
Another red algal species, the Fijian Callophycus serratus, was found to produce eight 
bromophycolides J–Q (20–27)(Figure 4), which exhibited IC50 values against Plasmodium falciparum 
in the low micromolar range (44 for compound 22, 0.5 for 23, 1.4 for 24, 25 and 27)[39]. Antimalarian 
activity appeared to be associated with the presence of a macrolide motif in the chemical structure of 
these molecules. Antibacterial assays were performed using methicillin-resistant Staphylococcus 
aureus and vancoymcin-resistant Enterococcus faecium as test pathogens. The macrolides were also 
evaluated against a panel of 12 tumor cell lines including breast, colon, lung, prostate, and ovarian 
cancer cells. Of the eight tested compounds, bromophycolides 26 and 27 exhibited the most potent 
antibacterial activity against S. aureus and E. faecium, suggesting that conformational rigidity and/or 
hydrophobicity conferred by the tetrahydropyran system contributes to antibacterial activity. While all 
tested bromophycolides exhibited moderate antineoplastic activity, only 24 displayed some cell line 
selectivity, with an IC50 of 1.5 μM against the breast tumor cell line. Interestingly, while 24 Mar. Drugs 2010, 8                          
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demonstrated cancer cell line selectivity, its regioisomer 23 was quite active against all cancer cell 
lines tested (IC50’s 2.1–7.2 μM). Bromophycolide 27 was the most potent C. serratus natural product 
evaluated but showed little cell line selectivity. 
Figure 3. Structures of monoterpenes 15–19 isolated from Plocamium cornutum. 
 
Figure 4. Structures of bromophycolides 20–27 from Callophycus serratus. 
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Halogenated metabolites from brown algae, reported as unusual for this algal group [40], have been 
found to be mainly terpenes. However, some new molecules were reported for brown algae in 2009. A 
new halogenated meroditerpenoid, fallachromenoic acid (28)(Figure 5), was isolated from the southern 
Australian brown algae Sargassum fallax, and displayed antitumor activities against a P388 Murine 
Leukaemia cell line [41]. Although there were no previous reports of halogenated compounds in the 
Stypopodium genus, Areche et al. [40] found an unusual 40-chlorostypotriol triacetate (29)(Figure 5) 
in Stypopodium flabelliforme, from which biological properties are still unknown. Another brown algal 
species, Dictyopteris divaricata, was found to produce two new brominated selinane sesquiterpenes,  
1-bromoselin-4(14),11-diene (30) and 9-bromoselin-4(14),11-diene (31)[42](Figure 5). 
No reports associated with green algae were found in the selected bibliography from 2009. 
Figure 5. Structures of compounds 28–31 isolated from brown algae. 
 
3. Cyanobacteria 
Marine phytoplankton has been much less investigated than macroalgae although marine 
microorganisms are, in general, increasingly considered successful sources of natural products. Earlier 
reviews and reports on marine natural products including phytoplankton refer mainly to cyanobacteria 
and dinoflagellates [9,18,43,44] as sources of natural compounds. 
Selected examples of recently discovered halogenated molecules produced by marine 
phytoplankton, from 2009 literature, exhibited the same trend. Among phytoplankton major groups, 
cyanobacteria have come forward as one of the most promising groups of microorganisms for the 
isolation of interesting new natural halogenated compounds [45,46]. A wide range of compounds with 
different properties is produced by these blue-green algae [44]. For example, many of these 
compounds were found to be anticancer agents or powerful neurotoxins performing either as blockers 
or activators of the eukaryotic voltage-gated sodium (Nav) channels [44]. 
Cyanobacterial toxins have received increased research effort in recent years [47–49] because these 
molecules are among the most found hazardous substances in surface waters and occurrence of 
harmful cyanobacterial bloom events is rising worldwide [50].  
The cyanobacteria Lyngbya majuscula, from an Eastern Caribbean collection, was found to produce 
two new halogenated fatty acid amides, grenadamides B and C (32–33), and two new depsipeptides, Mar. Drugs 2010, 8                          
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itralamides A and B (34–35)[51](Figure  6). The first two compounds displayed marginal activity 
against the beet armyworm (Spodoptera exigua).  
Figure 6. Structures of compounds 32–35 isolated from the cyanobacteria   
Lyngbya majuscula. 
 
From the same genus, a new brominated compound, lyngbyastatin 10 (36)(Figure 7), closely related 
to lyngbyastatins, was found in Lyngbya semiplena, collected in Tumon Bay (Guam, Pacific ocean), 
inhibiting porcine pancreatic elastase [52]. Another cyanobacteria, Fischerella ambigua, obtained from 
a culture, produces five newly found antibacterial chlorinated molecules, ambiguine K–O isonitriles 
(37–41)[53](Figure  7). Ambiguine K and M isonitriles showed the most potent activity against 
Mycobacterium tuberculosis, the causal agent of most cases of tuberculosis. Ambiguine A isonitrile 
was the most active one against Bacillus anthracis, the bacterium that causes anthrax. A new 
brominated indole alkaloid, named as bromoanaindolone, (IUPAC name: 6-bromo-3-hydroxy-3-
methyl-indol-2-one)(42)(Figure 7), yielded by the cyanobacteria Anabaena constricta [54], showed Mar. Drugs 2010, 8                          
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antibacterial activity against the Gram-positive species Bacillus cereus, the bacterium that causes 
foodborne disease commonly known as food poisoning. Bromoanaindolone also displayed 
anticyanobacterial activity against the filamentous species Arthrospira laxissima and Nostoc carneum, 
and also against the unicellular species Chroococcus minutus,  Synechocystis aquatilis and 
Synechococcus sp., which indicates the allelopathic potential of this compound. 
Figure 7. Structures of compounds 36–42 isolated from cyanobacteria. 
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4. Limitations and Possible Solutions to Detection of Bioactivity 
The fact that some of the newly found halogenated compounds show minor or no activity at all 
against a specific target does not exclude the possibility of other hidden unidentified active biological 
effects. Additionally, the supposedly absence of bioresponse may be related to limitations in the Mar. Drugs 2010, 8                          
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analytical chemistry methods employed. Bioassay-guided fractionation is the iterative approach 
traditionally applied to disclose bioactive natural compounds [55,56]. Difficulties in perception of 
bioactivity may be linked to compound instability, caused by fractionation and isolation from the 
natural cellular environment or simply because compounds may act synergistically or more than one 
compound may be associated to a specific property. This is particularly true for macroalgae and 
microalgae which are complex compound matrices [57]. Metabolite-oriented approaches, namely 
metabolite profiling and metabolomics, may supplement bioassay-guided fractionation [58]. These two 
approaches are focused on the chemical properties of the metabolome, which includes the complete set 
of metabolites of an organism (metabolomics), or of a limited group of pre-defined metabolites 
(metabolite profiling)[59]. In the latter approach, pre-defined metabolites are selected either according 
to the class they belong to (organic phosphates, carbohydrates, etc.) or to an associated specific 
pathway. Both metabolite profiling and metabolomics allow all compounds to be simultaneously 
measured, so that detection of unstable compounds is facilitated and synergistic effects detected [59]. 
Also, the influence of a particular condition on the organism physiology can be revealed through 
qualitative and quantitative differences in the metabolic profiles obtained [60,61]. This could be a 
valuable tool for the assessment of effects of environmental changes on the community structure and 
organism physiology. However, useful metabolomics may be used for a more thorough and complete 
detection of metabolites, limitations subsist when applied to chemical ecology, due to the difficulty in 
establishing a link between one or more specific metabolites and an ecological role [58]. 
Other techniques have been applied for the study of halogenated compounds in marine algae. 
Desorption electrospray ionization mass spectrometry (DESI-MS) and some applications, such as 
imaging, have very recently started to be used for natural products detection on intact algal tissue 
surfaces [62,63]. DESI-MS is an ambient ionization technique coupled with mass spectrometry, 
allowing probing the surface of solids, liquids, frozen solutions, and adsorbed gases [64]. In ambient 
DESI-MS, samples are kept under atmospheric pressure in open air, with minimum or no preparation 
at all [64]. Tissue surfaces are subject to a focused spray of charged particles of a polar solvent, which 
leads to the release of intact gaseous ions from surfaces into the mass spectrometer [65]. Low detection 
limits and high analysis speed are achieved, and innate chemical information is preserved to a 
maximum [64]. DESI-MS has been shown to be a sensitive and effective approach to detect algal 
diterpene-benzoate macrolide natural products, namely bromophycolides, directly on the surface and 
interior of a marine red alga, Callophycus serratus [62]. Reactive DESI approaches were investigated 
to improve ionization efficiency and detection limits. Different polar solvent compositions, tested 
directly on the algal surfaces, were demonstrated to enhance sensitivity for discovery of various 
bromophycolides, which would have otherwise been undetected. Imaging, one of DESI-MS possible 
applications, has been shown to provide an exceptional capability to map secondary metabolites to 
distinct algal surface sites [63]. Bromophycolides were shown to be non homogenously distributed 
across surfaces but instead associated with distinct patches, again in the red algae Callophycus 
serratus. DESI-MS imaging appears to be a powerful tool for the investigation of the function of 
surface-associated natural products in ecological interactions, as spatially-resolved measurements with 
lateral resolutions in the hundreds of micrometers are made possible. These studies [62,63] illustrate 
the potential of DESI-MS and its applications, such as imaging, in understanding chemically-mediated 
biological processes in macroalgae. Mar. Drugs 2010, 8                          
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5. Ecological Role  
Micro and macroalgal survival and success in the marine environment reflect to a great extent the 
many strategies these organisms have had to employ throughout their evolutionary history to adapt to a 
hostile and high resource-demanding milieu. Extreme competition for space, light and nutrients has 
shaped the organisms’ physiology, resulting in a complex array of biologically active metabolites 
characteristic of each species. Many of these secondary metabolites have been shown to support the 
defense mechanisms developed by marine algae [66–69]. Secondary metabolites are now suggested to 
be responsible for marine biodiversity on the genetic, species, and ecosystem levels [70,71].  
Chemical ecology, which tackles the role of natural compounds in the interactions between 
organisms and also between organisms and their environment, has already a few decades of 
investigation dedicated to marine systems [46]. Historically, interest in natural products from marine 
algae was initially driven to meet pressing biomedical requirements for new drugs against fungal [72], 
parasitic [73], bacterial [74], and viral [75] diseases, which were either used in their natural form or as 
templates for synthesis and further chemical structure modification [46]. For this purpose, macroalgae 
from tropical areas were heavily screened and many new halogenated compounds were found in the 
last decade [18]. Apart from potent and original therapeutic agents for infectious diseases and cancer, 
among many other disorders, natural products isolated from marine algae were also found to clearly 
control interactions between organisms [11–13], and therefore influence population structure, 
communities organization, and ecosystem function [14–17]. Biodiversity in marine systems may be a 
result of chemical diversity [68]. Presently, specific ecological aspects such as chemical sensing of the 
environment by algae, intraspecific signaling, allelopathy, predator-prey and host-parasite interactions, 
and bioaccumulation and transfer of toxins within food webs have been addressed on recent research 
on the ecology of natural compounds from marine algae. Excellent reviews and essays on marine 
chemical ecology covering years prior to 2009 have been published (see [3,17,68,76–78]), however, 
with no particular focus on halogenated compounds. Interactions between algae and herbivorous 
invertebrates or describing allelopathic effects have received most of the attention. These ecological 
interactions continue to be predominantly documented from an ecological   
perspective [79,80]; the chemical identification of compounds responsible for the found ecological 
relationships was overlooked during 2009. A multidisciplinary approach including organic chemistry, 
biology, and ecology components is required for the in depth elucidation of the ecological 
relationships in the near future. So far, the ecological and the chemical approaches rarely coincide in 
the same study; the cellular and molecular bases for these interactions remain disregarded. In fact, to 
the best of our knowledge, an ecological study on marine macroalgae, including elucidation of 
chemical structure of molecules responsible for ecological interactions, was found during 2009. A 
direct fine-scale evaluation of bromophycolides and callophycoic acids was conducted on red 
macroalga Callophycus serratus surfaces in order to evaluate whether these natural compounds had a 
role in surface-mediated defense against pathogenic microbes [63]. These novel compounds had been 
reported for the first time in C. serratus [39], represent the largest group of algal antifungal compounds 
described to date, and were shown to inhibit growth of Lindra thalassiae, a marine pathogenic   
fungus [63]. DESI-MS imaging revealed bromophycolides among heterogeneous patches on algal 
surfaces and within internal algal tissues. The bromophycolide concentrations found on these surface Mar. Drugs 2010, 8                          
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patches were sufficient suppress growth of L. thalassia, indicating that probably these compounds are 
kept internally and released at sparsely distributed surface sites. The above cited study [63] provides 
the first direct evidence for localization of chemical signals with spatial resolution <200  µm on 
biological surfaces in concentrations sufficient for targeted antimicrobial defense, highlighting the 
potential of DESI-MS imaging for the understanding of small-scale ecological interactions.  
6. Present Trends  
A lot still remains to be done concerning research on the role of marine natural halogenated 
compounds: (i) isolation and characterization of new halogenated compounds (ii) screening untested 
micro and macroalgal species (iii) improving assessment in the detection of bioactivities, fully 
exploring potential of metabolite-oriented approaches, (iv) testing biomedical and ecological relevance 
of novel and known chemical natural compounds, (v) ensuring reliable taxonomic identification of 
investigated species, (vi) biogeographical assessing of micro- and macroalgae with relevant 
compounds, and (vii) developing appropriate strategies for data management.  
From a purely ecological point of view, success toward the in-depth understanding of marine 
ecological interactions is very much dependent on a multidisciplinary approach, relying on adequate 
bioactivity detection methodologies. Chemical metabolite-oriented approaches may prove to be 
reliable tools helping to elucidate compound’s biological properties, which may not be detectable in 
any other way. Ecological studies may just benefit from an interactive and close combination of 
chemical methodologies with ecological experiments. 
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